14 Apr Study finds COVID-19, Type 2 Diabetes Share Disease Pathways

MedicalResearch.com Interview with:

Dr. Drucker

Daniel J. Drucker, M.D.
Lunenfeld-Tanenbaum
Research Institute
Mount Sinai Hospital
Toronto 

MedicalResearch.com: What is the background for this study? What are the main findings?

Response: This review was prompted by shared mechanistic pathways linking actions of molecules such as ACE2 and DPP4, which are important enzymes with cardiometabolic actions, yet also function as coronavirus receptors. The recognition that people with diabetes and obesity are more prone to severe infection also highlights the importance of understanding the biology

We highlight the intersection of pathways shared by coronavirus infection, and how these might impact our understanding of diabetes and its therapies.

MedicalResearch.com: What should readers take away from your report?

Response: People with diabetes and obesity have higher rates of hospitalization and more severe clinical illness with SARS-CoV-2 coronavirus infection. There are likely adjustments to medications used to treat diabetes that should be considered in hospitalized patients with type 2 diabetes

MedicalResearch.com: What recommendations do you have for future research as a result of this work?

Response: We need to understand whether any of the medications we use for type 2 diabetes therapy have any special benefits or risks that are currently not appreciated, in the context of active Coronavirus infection 

Disclosures listed in article

Citation:

Daniel J Drucker M.D.

“Coronavirus infections and type 2 diabetes-shared pathways with therapeutic implications,” was published online, ahead of print.

[subscribe]

[last-modified]

The information on MedicalResearch.com is provided for educational purposes only, and is in no way intended to diagnose, cure, or treat any medical or other condition. Always seek the advice of your physician or other qualified health and ask your doctor any questions you may have regarding a medical condition. In addition to all other limitations and disclaimers in this agreement, service provider and its third party providers disclaim any liability or loss in connection with the content provided on this website.

Last Updated on May 12, 2020 by Marie Benz MD FAAD